Ann: Shareholder Update - Frequently Asked Questions, page-9

So my considerations:

Can another wound care company buy the IP and access all the patents and potentially re-engineer VF001 and re do a study>?? IT may have some value in a sale??

Also cash position is about 1.5-2 million and their 2017 R&D return was over 3 million. So I assume a tax return for 2018 may be more? (submitted in Jan as per their statement ?

Might take the value of the company somewhere around $5million plus value of IP (? what is this priced at?)

Fair value in 2 months may .005-.006?
Worth a hold (despite the loss)